Interplay between human high mobility group protein 1 and replication protein A on psoralen-cross-linked DNA

Biochemistry

Volumn 44, Issue 11, 2005, Pages 4188-4195

  Reddy, Madhava C ^a   Christensen, Jesper ^b   Vasquez, Karen M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHROMOSOMES; CROSSLINKING; DNA; PHYSIOLOGY; SENSITIVITY ANALYSIS;

HUMAN MOBILITY GROUP BOX (HMGB); INTERSTRAND CROSS-LINK (ICL); NUCLEOTIDE EXCISION REPAIR (NER); REPLICATION PROTEIN A (RPA);

PROTEINS;

CHROMOSOME PROTEIN; CISPLATIN; DIHYDROXYBENZO[A]PYRENE OXIDE; DNA; HIGH MOBILITY GROUP B PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; PSORALEN; REPLICATION PROTEIN A;

ARTICLE; CELL DEATH; CHROMATIN STRUCTURE; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA METABOLISM; DRUG DNA BINDING; EXCISION REPAIR; GENETIC CONSERVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN FUNCTION; ULTRAVIOLET C RADIATION;

BASE SEQUENCE; BINDING, COMPETITIVE; DNA; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA-BINDING PROTEINS; HMGB1 PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID HETERODUPLEXES; OLIGONUCLEOTIDES; PROTEIN BINDING; REPLICATION PROTEIN A; TRIOXSALEN; ULTRAVIOLET RAYS;

EID: 15544366698     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi047902n     Document Type: Article

References (60)

1. Agresti, A., and Bianchi, M. E. (2003) HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 13, 170-178.
2. Bustin, M. (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins, Mol. Cell. Biol. 19, 5237-5246.
3. Thomas, J. O., and Travers, A. A. (2001) HMG1 and 2, and related 'architectural' DNA-binding proteins, Trends Biochem. Sci. 26, 167-174.
4. Yang, H., Wang, H., Czura, C. J., and Tracey, K. J. (2002) HMGB1 as a cytokine and therapeutic target, J. Endotoxin Res. 8, 469-472.
5. Degryse, B., and de Virgilio, M. (2003) The nuclear protein HMGB1, a new kind of chemokine?, FEBS Lett. 553, 11-17.
6. Andersson, U., and Tracey, K. J. (2003) HMGB1 in sepsis, Scand. J. Infect. Dis. 35, 577-584.
7. Czura, C. J., Wang, H., and Tracey, K. J. (2001) Dual roles for HMGB1: DNA binding and cytokine. J. Endotoxin. Res. 7, 315-321.
8. Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, P., Ferrari, S., and Bianchi, M. E. (1999) The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice, Nat. Genet. 22, 276-280.
9. Ronfani, L., Ferraguti, M., Croci, L., Ovitt, C. E., Scholer, H. R., Consalez, G. G., and Bianchi, M. E. (2001) Reduced fertility and spermatogenesis detects in mice lacking chromosomal protein Hmgb2, Development 128, 1265-1273.
10. Lilley, D. M. (1992) DNA-protein interactions. HMG has DNA wrapped up, Nature 357, 282-283.
11. Cerdan, R., Payet, D., Yang, J. C., Travers, A. A., and Neuhaus, D. (2001) HMG-D complexed to a bulge DNA: An NMR model, Protein Sci. 10, 504-518.
12. Gibb, C. L., Cheng, W., Morozov, V. N., and Kallenbach, N. R. (1997) Effect of nuclear protein HMG1 on in vitro slippage synthesis of the tandem repeat dTG x dCA, Biochemistry 36, 5418-5424.
13. Payet, D., Hillisch, A., Lowe, N., Diekmann, S., and Travers, A. (1999) The recognition of distorted DNA structures by HMG-D: A footprinting and molecular modelling study, J. Mol. Biol. 294, 79-91.
14. Bianchi, M. E., Beltrame, M., and Paonessa, G. (1989) Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243, 1056-1059.
15. Bianchi, M. E., Falciola, L., Ferrari, S., and Lilley, D. M. (1992) The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins, Embo. J. 11, 1055-1063.
16. JR. P. o., Norman, D. G., Bramham, J., Bianchi, M. E., and Lilley, D. M. (1998) HMG box proteins bind to four-way DNA junctions in their open conformation, EMBO J. 17, 817-826.
17. Hamada, H., and Bustin, M. (1985) Hierarchy of binding sites for chromosomal proteins HMG 1 and 2 in supercoiled deoxyribonucleic acid, Biochemistry 24, 1428-1433.
18. Jung, Y., and Lippard, S. J. (2003) Nature of full-length HMGB1 binding to cisplatin-modified DNA, Biochemistry 42, 2664-2671.
19. Pil, P. M., and Lippard, S. J. (1992) Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin, Science 256, 234-237.
20. Farid, R. S., Bianchi, M, E., Falciola, L., Engelsberg, B. N., and Billings, P. C. (1996) Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA. Toxicol. Appl. Pharmacol. 141, 532-539.
21. Lanuszewska, J., and Widlak, P. (2000) High mobility group 1 and 2 proteins bind preferentially to DNA that contains bulky adducts induced by benzo[a]pyrene diol epoxide and N-acetoxy-acetylaminofluorene, Cancer Lett. 158, 17-25.
22. Wang, J. F., Bashir, M., Engelsberg, B. N., Witmer, C., Rozmiarek, H., and Billings, P. C. (1997) High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis 18, 371-375.
23. Pasheva, E. A., Pashev, I. G., and Favre, A. (1998) Preferential binding of high mobility group 1 protein to UV-damaged DNA. Role of the COOH-terminal domain. J. Biol Chem. 273, 24730-24736.
24. Nagatani, G., Nomoto, M., Takano, H., Ise, T., Kato, K., Imamura, T., Izumi, H., Makishima, K., and Kohno, K. (2001) Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells. Cancer Res. 61, 1592-1597.
25. Zamble, D. B., Mikata, Y., Eng, C. H., Sandman, K. E., and Lippard, S. J. (2002) Testis-specific HMG-domain protein alters the responses of cells to cisplatin, J. Inorg. Biochem. 91, 451-462.
26. Malina, J., Kasparkova, J., Natile, G., and Brabec, V. (2002) Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts, Chem. Biol. 9, 629-638.
27. He, Q., Liang, C. H., and Lippard, S. J. (2000) Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin, Proc. Natl. Acad. Sci. U.S.A. 97, 5768-5772.
28. Patrick, S. M., and Turchi, J. J. (1998) Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro, Biochemistry 37, 8808-8815.
29. Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., and Sancar, A. (1994) HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. U.S.A. 91, 10394-10398.
30. Joerges, C., Kuntze, I., and Herzinge, T. (2003) Induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiation, Oncogene 22, 6119-6128.
31. Dronkert, M. L., and Kanaar, R. (2001) Repair of DNA interstrand cross-links, Mutat. Res. 486, 217-247.
32. Vasquez, K. M., and Wilson, J. H. (1998) Triplex-directed modification of genes and gene activity. Trends Biochem. Sci. 23, 4-9.
33. Vasquez, K, M., and Glazer, P. M. (2002) Triplex-forming oligonucleotides: Principles and applications. Q. Rev. Biophys. 35, 89-107.
34. Praseuth, D., Guieysse, A. L., and Helene, C. (1999) Triple helix formation and the antigene strategy for sequence-specific control of gene expression, Biochim. Biophys. Acta 1489, 181-206.
35. Vasquez, K. M., Narayanan, L., and Glazer, P. M. (2000) Specific mutations induced by triplex-forming oligonucleotides in mice, Science 290, 530-533.
36. Vasquez, K. M., Wang, G., Havre, P. A., and Glazer, P. M. (1999) Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells, Nucleic Acids Res. 27, 1176-1181.
37. Vasquez, K. M., Marburger, K., Intody, Z., and Wilson, J. H. (2001) Manipulating the mammalian genome by homologous recombination, Proc. Natl. Acad. Sci. U.S.A. 98, 8403-8410.
38. Datta, H. J., Chan, P. P., Vasquez, K. M., Gupta, R. C. and Glazer, P. M. (2001) Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51, J. Biol. Chem. 276, 18018-18023.
39. Vasquez, K. M., Wensel, T. G., Hogan, M. E., and Wilson, J. H. (1996) High-efficiency triple-helix-mediated photo-cross-linking at a targeted site within a selectable mammalian gene, Biochemistry 35, 10712-10719.
40. Oh, D. H., and Hanawalt, P. C. (2000) Binding and photoreactivity of psoralen linked to triple helix-forming oligonucleotides, Photochem. Photobiol. 72, 298-307.
41. Vasquez, K. M., Christensen, J., Li, L., Finch, R. A., and Glazer, P. M. (2002) Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions, Proc. Natl. Acad. Sci. U.S.A. 99, 5848-5853.
42. Majumdar, A., Puri, N., Cuenoud, B., Natt, F., Martin, P., Khorlin, A., Dyatkina, N., George, A. J., Miller, P. S., and Seidman, M. M. (2003) Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide, J. Biol. Chem. 278, 11072-11077.
43. Wang, G., Seidman, M. M., and Glazer, P. M. (1996) Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair, Science 271, 802-805.
44. Aboussekhra, A., Biggerstaff, M., Shivji, M. K., Vilpo, J. A., Moncollin, V., Podust, V. N., Protic, M., Hubscher, U., Egly, J. M., and Wood, R. D. (1995) Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 80, 859-868.
45. Mu, D., Park, C. H., Matsunaga, T., Hsu, D. S., Reardon, J. T., and Sancar, A. (1995) Reconstitution of human DNA repair excision nuclease in a highly defined system. J. Biol. Chem. 270, 2415-2418.
46. Schramke, V., Luciano, P., Brevet, V., Guillot, S., Corda, Y., Longhese, M. P., Gilson, E., and Geli, V. (2004) RPA regulates telomerase action by providing Est1p access to chromosome ends, Nat. Genet. 36, 46-54.
47. Robbins, J. B., Murphy, M. C., White, B. A., Mackie, R. I., Ha, T., and Cann, I. K. (2004) Functional analysis of multiple single-stranded DNA-binding proteins from Methanosarcina acetivorans and their effects on DNA synthesis by DNA polymerase BI, J. Biol. Chem. 279, 6315-6326.
48. Cotmore, S. F., and Tattersall, P. (1998) High-mobility group 1/2 proteins are essential for initiating rolling-circle-type DNA replication at a parvovirus hairpin origin, J. Virol. 72, 8477-8484.
49. Cotmore, S. F., Christensen, J., and Tattersall, P. (2000) Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rolling-hairpin replication origin, J. Virol. 74, 1332-1341.
50. Christensen, J., Cotmore, S. F., and Tattersall, P. (1995) Minute virus of mice transcriptional activator protein NS1 binds directly to the transactivation region of the viral P38 promoter in a strictly ATP-dependent manner, J. Virol. 69, 5422-5430.
51. Christensen, J., and Tattersall, P. (2002) Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system, J. Virol. 76, 6518-6531.
52. Vasquez, K. M., Wensel, T. G., Hogan, M. E., and Wilson, J. H. (1995) High-affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene, Biochemistry 34, 7243-7251.
53. You, J. S., Wang, M., and Lee, S. H. (2003) Biochemical analysis of the damage recognition process in nucleotide excision repair, J. Biol. Chem. 278, 7476-7485.
54. Brezniceanu, M. L., Volp, K., Bosser, S., Solbach, C., Lichter, P., Joos, S., and Zornig, M. (2003) HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma, FASEB J. 17, 1295-1297.
55. Lotze, M. T., and DeMarco, R. A. (2003) Dealing with death: HMGB1 as a novel target for cancer therapy, Curr. Opin. Investig. Drugs 4, 1405-1409.
56. Pasheva, E. A., Ugrinova, I., Spassovska, N. C., and Pashev, I. G. (2002) The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity, Int. J. Biochem. Cell Biol. 34, 87-92.
57. Jayaraman, L., Moorthy, N. C., Murthy, K. G., Manley, J. L., Bustin, M., and Prives, C. (1998) High mobility group protein-1 (HMG-1) is a unique activator of p53, Genes Dev. 12, 462-472.
58. McKinney, K., and Prives, C. (2002) Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein, Mol. Cell. Biol. 22, 6797-6808.
59. Imamura, T., Izumi, H., Nagatani, G., Ise, T., Nomoto, M., Iwamoto, Y., and Kohno, K. (2001) Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein, J. Biol. Chem. 276, 7534-7540.
60. Thoma, B. S., and Vasquez, K. M. (2003) Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair, Mol. Carcinog. 38, 1-13.